Replay: Exploring the Potential of Mahana’s Innovative Digital Treatments for IBS

DTx Podcast with Eugene Borukhovich

English - August 29, 2023 07:08 - 38 minutes - ★★★★★ - 9 ratings
Health & Fitness Technology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Replay: The Video Game Tackling the Youth Mental Health Crisis

Next Episode: Ep73: Beyond Adherence: Transforming Chronic Care Management with Digital Health

Have you heard? On August 22, Mahana Therapeutics announced a distribution and marketing partnership with Bayer’s consumer health division. This partnership unites Mahana’s proficiency in digital therapeutic advancement with Bayer’s commitment to empowering individuals through cutting-edge digital solutions, all aimed at enabling greater personal health control. The full press release is linked below.
In light of this, we’re bringing you this replay episode with Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana.
In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app.

In this episode, we cover:

The founding story and funding journey of Mahana

Complexities of the end to end patient experience

The freemium model and how that translates into a PDT

Evidence generation and FDA clearance process

Scaling plans for PDTs

Guest Links and Resources:

Press Release about the Mahana and Bayer partnership

Connect with Simon Levy on LinkedIn

Connect with Ann Montgomery on LinkedIn

Visit Mahana.com

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn

Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn

Connect with YourCoach.health: Website | Twitter

Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App

HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health | Orion Pharma

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In light of this, we’re bringing you this replay episode with Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana.

In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app.

In this episode, we cover:

The founding story and funding journey of Mahana
Complexities of the end to end patient experience
The freemium model and how that translates into a PDT
Evidence generation and FDA clearance process
Scaling plans for PDTs

Guest Links and Resources:

Press Release about the Mahana and Bayer partnership
Connect with Simon Levy on LinkedIn